These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12464112)

  • 1. Design, expression, and characterization of a synthetic human cannabinoid receptor and cannabinoid receptor/ G-protein fusion protein.
    Farrens DL; Dunham TD; Fay JF; Dews IC; Caldwell J; Nauert B
    J Pept Res; 2002 Dec; 60(6):336-47. PubMed ID: 12464112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.
    Shire D; Calandra B; Delpech M; Dumont X; Kaghad M; Le Fur G; Caput D; Ferrara P
    J Biol Chem; 1996 Mar; 271(12):6941-6. PubMed ID: 8636122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
    Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
    Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
    Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.
    Murphy JW; Kendall DA
    Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
    Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
    Meschler JP; Kraichely DM; Wilken GH; Howlett AC
    Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.
    Shire D; Calandra B; Bouaboula M; Barth F; Rinaldi-Carmona M; Casellas P; Ferrara P
    Life Sci; 1999; 65(6-7):627-35. PubMed ID: 10462063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling.
    Nie J; Lewis DL
    Neuroscience; 2001; 107(1):161-7. PubMed ID: 11744255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells.
    Abood ME; Ditto KE; Noel MA; Showalter VM; Tao Q
    Biochem Pharmacol; 1997 Jan; 53(2):207-14. PubMed ID: 9037253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange.
    Kearn CS; Greenberg MJ; DiCamelli R; Kurzawa K; Hillard CJ
    J Neurochem; 1999 Jun; 72(6):2379-87. PubMed ID: 10349847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
    Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.
    Burkey TH; Quock RM; Consroe P; Ehlert FJ; Hosohata Y; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 Oct; 336(2-3):295-8. PubMed ID: 9384246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration.
    Nie J; Lewis DL
    J Neurosci; 2001 Nov; 21(22):8758-64. PubMed ID: 11698587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CB1 cannabinoid receptor in the brain.
    Howlett AC
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):405-16. PubMed ID: 9974174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
    Fay JF; Farrens DL
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction.
    Howlett AC; Wilken GH; Pigg JJ; Houston DB; Lan R; Liu Q; Makriyannis A
    J Neurochem; 2000 May; 74(5):2174-81. PubMed ID: 10800963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity.
    Zádor F; Kocsis D; Borsodi A; Benyhe S
    Neurochem Int; 2014 Feb; 67():14-22. PubMed ID: 24508403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SR144528 as inverse agonist of CB2 cannabinoid receptor.
    Rhee MH; Kim SK
    J Vet Sci; 2002 Sep; 3(3):179-84. PubMed ID: 12514329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.